哈梅内伊强调伊朗不会屈服于侵略 智通财经6月24日电，据CCTV国际时讯，当地时间6月23日晚，北京时间今天（6月24日）凌晨，在伊 朗对卡塔尔境内驻有美军的乌代德空军基地发动报复性导弹袭击后，伊朗最高领袖哈梅内伊的社媒账号 发帖，内容为："我们未曾侵略他人，也绝不接受任何人的侵略，更不会屈服于任何人的侵略。这就是 伊朗民族的逻辑。 ...

Hims & Hers Health ((HIMS) has been one of the market’s standout growth stocks in recent years. The company has successfully built a direct-to-consumer health platform targeting conditions like hair loss, mental health, and more recently, weight loss—delivering very strong revenue growth and stock returns.Shares had soared more than 150% (on two separate occasions) through the first half of 2025 before crashing more than 30% on Monday following a major partnership setback.The selloff was triggered by news t ...

We are currently offering a free two-week trial to Distressed Value Investing . Join our community to receive exclusive research about various companies and other opportunities along with full access to my portfolio of historic research that now includes over 1,000 reports on over 100 companies.Black Stone Minerals (NYSE: BSM ) reported relatively low Q1 2025 production levels that were approximately 10% lower than its guidance midpoint for the year. It has left its full-year guidance unchanged though and w ...

Group 1 - CoreWeave (CRWV) has been rated a 'Hold' due to its strong growth trajectory, but concerns exist regarding its capital-intensive model, questionable unit economics, and high debt levels [1] - The focus of PropNotes is on identifying high-yield investment opportunities for individual investors, simplifying complex concepts, and providing actionable insights for better returns [1] Group 2 - The article emphasizes that past performance does not guarantee future results and that no specific investment recommendations are being made [3] - It is noted that the views expressed may not reflect those of Seeking Alpha as a whole, and the analysts involved may not be licensed or certified [3]

Group 1 - The document contains fragmented and unclear information, making it difficult to extract coherent insights regarding any specific company or industry [1][2][3]. - There are references to various numerical data points, but without context or clarity, their significance remains ambiguous [1][3]. - The author, Neils Christensen, has a background in journalism and financial reporting, which may lend credibility to any future analyses or articles [4]. Group 2 - The content does not provide any actionable insights or detailed analysis relevant to investment opportunities or risks within a specific industry or company [5].

证券代码：688213 证券简称：思特威 公告编号：2025-025 思特威（上海）电子科技股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股现金红利0.15元 ● 相关日期 ■ 一、通过分配方案的股东大会届次和日期 本次利润分配方案经思特威（上海）电子科技股份有限公司（以下简称"公司"）2025年5月30日的2024 年年度股东大会审议通过。 二、分配方案 1.发放年度：2024年年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分公司（以下简 称"中国结算上海分公司"）登记在册的本公司全体股东。 3.差异化分红送转方案： 根据公司2024年年度股东大会审议通过的《关于2024年度利润分配预案的议案》，公司拟以实施权益分 派的股权登记日登记的公司总股本扣减公司回购专用证券账户中股份为基数，向全体股东每1股派发现 金红利0.15元（含税），不进行资本公积转增股本，亦不派送红股。如在实施权益分派股权登记日前， 公司总股 ...

ToplineThe initial rollout of Tesla’s “robotaxi” driverless vehicle cabs inspired a major rally for Elon Musk’s automaker, making the company’s CEO and top shareholder Musk, already the world’s wealthiest person Elon Musk, billions of dollars richer.Tesla stock surged following the initial rollout of its robotaxi program in Austin.© 2025 Bloomberg Finance LPKey FactsShares of Tesla shot up 9%, or $29, by late afternoon, registering a three-week high share price of more than $350. Musk, who owns 13% of Tesl ...

据美国商品期货交易委员会(CFTC)：在截至6月17日的一周内，投机者将COMEX黄金净多头头寸增加 6775手，至13.66万手；将COMEX白银净多头头寸增加1240手，至50034手；将COMEX铜净多头头寸减 少3051手，至23625手。(智通财经) ...

Core Insights - Iovance Biotherapeutics Inc. is undergoing a leadership transition with the resignation of CFO Jean-Marc Bellemin, effective July 10, 2025, amid commercial challenges and a class-action lawsuit [1][2][3] Group 1: Leadership Changes - CFO Jean-Marc Bellemin is resigning to pursue other endeavors, having served since November 2020 [1][2] - The company has not yet named a successor for the CFO position, creating uncertainty during a challenging period [2] Group 2: Commercial Performance - Iovance's flagship drug, Amtagvi, has significantly underperformed, leading to a downward revision of full-year revenue projections [3][6] - First-quarter sales figures for Amtagvi fell short of Wall Street expectations, prompting a downgrade from UBS [3] Group 3: Legal Challenges - Iovance is facing a securities fraud class-action lawsuit related to its portrayal of authorized treatment centers (ATCs) crucial for Amtagvi's administration [4][5] - The lawsuit alleges discrepancies between the company's claims about ATC operations and the actual performance, including delays in patient treatment initiation and high patient drop-off rates [5][6] Group 4: Market Reaction - Following the disclosure of disappointing first-quarter results and revised revenue guidance, Iovance's stock price dropped over 44%, from $3.17 to $1.75 per share within a day [6][7] - The market's swift reaction reflects investor concerns regarding the company's commercial execution and the accuracy of its operational updates [7]

登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 江苏九鼎新材（维权）料股份有限公司 关于担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、担保事项的概述 江苏九鼎新材料股份有限公司（以下简称"公司"）于2025年4月18日召开的公司第十一届董事会第二次 会议、2025年5月15日召开的2024年度股东大会审议通过《关于公司2025年担保额度预计的议案》，其 中同意公司为全资子公司九鼎新材料有限公司（以下简称"九鼎材料"）提供总额不超过50,000万元担保 额度，为全资孙公司江苏九鼎建筑新材料有限公司（以下简称"九鼎建材"）提供总额不超过10,000万元 担保额度，为全资孙公司江苏九鼎特种纤维有限公司（以下简称"九鼎特纤"）提供总额不超过10,000万 元担保额度。具体内容详见公司分别于2025年4月22日、2025年5月16日披露在《证券时报》及巨潮资讯 网（http://www.cninfo.com.cn）的《公司第十一届董事会第二次会议决议公告》（公告编号：2025- 14）、《公司关于2025年担保额度预计的公告》（公告编号：20 ...